Abstract
The in vivo metabolism, in rats, of ethinamate (1-ethynylcyclohexyl carbamate) was shown to be stimulated by pretreatment with phenobarbital and to be inhibited by 2, 4-dichiloro-6-phenylphenoxyethylamine (DPEA) and 2-chloro-6-phenylphenoxyethylamine (MPEA) as evidenced by parallel changes in plasma and brain ethinamate levels and half-lives and by sleeping times. Ethinamate was not abnormally distributed within the body and it did not bind strongly to plasma protens. The concentration of ethinamate in brain correlated closely with the plasma levels indicating that rapid equilibrium was established between the blood and brain compartments; MPEA was also found to inhibit the metabolism of ethinamate in dogs in vivo. In vitro studies with rat microsomes indicated that MPEA and DPEA exert their in vivo effects by inhibiting the conversion of ethinamate to hydroxyethinamate. These studies suggest that ethinamate may be a valuable model compound for the study of in vivo drug interactions.
Footnotes
- Received September 1, 1971.
- Accepted October 18, 1971.
- © 1972 by The Williams & Wilkins Co.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
